The relationship between waist circumference and biomarkers for diabetes and CVD in healthy non-obese women. The Pensacola study

Laboratory Medicine

Volumn 38, Issue 7, 2007, Pages 422-427

  Behan, Kristina Jackson ^a   Mbizo, Justice ^a  

^a UNIVERSITY OF WEST FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LABORATORY TEST; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 34447121486     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/VV1N2FGHNT84JKJF     Document Type: Article

References (31)

1. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care. 2002;25:742-749.
2. Mosca L. Heart disease prevention in women. Circulation. 2004;109: e158-e160.
3. Goede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Eng J Med. 2003;348:383-393.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
5. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
6. Pradhan AD, Cook NR, Buring JE, et al. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003;23:650-655.
7. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation. 2000;102:42-47.
8. Yeh ETH, Willerson JT. Coming of age of C-reactive protein. Using inflammatory markers in cardiology. Circulation. 2003;107:370-372.
9. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
10. American Diabetes Association. Available at: http://www.diabetes.org. Accessed on: 12/18/06.
11. American Heart Association. Available at: http://www.americanheart.org. Accessed on: 12/18/06.
12. World Health Organization. Obesity, preventing and managing the global epidemic: Report of a WHO consultation on obesity. Geneva, Switzerland: World Health Organization; 1997.
13. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet. 2005;366:1640-1649.
14. Obesity Education Initiative, National Institutes of Health, National Heart, Lung and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive Summary. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ ob_home.htm. Accessed on: 11/11/06.
15. Meisinger C, Doring A, Thorand B, et al. Body fat distribution and risk of type 2 diabetes in the general population: Are there differences between men and women? The MONICA/KORA Augsburg Cohort Study. Am J Clin Nutr. 2006;84:483-489.
16. Zhu S, Heshka S, Wang ZM, et al. Combination of BMI and waist circumference for identifying cardiovascular risk factors in whites. Obes Res. 2004;12:633-645.
17. Zhu S, Heymsfield SB, Toyoshima H, et al. Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr. 2005;81:409-415.
18. Mogul HZ, Weinstein BI, Mogul DB, et al. Syndrome W: A new model of hyperinsulinemia, hypertension and midlife weight gain in healthy women with normal glucose tolerance. Heart Disease. 2002;4:78-85.
19. Grundy SM, Cleeman JI, Daniels ST, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation. 2005;112:2735-2752.
20. Camargo JL, Gross JL. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method. J Clin Pathol. 2004;57:346-349.
21. Tarim O, Kucukerdogan A, Gunay U, et al. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int. 1999;41:357-362.
22. El-Agouza I, Abu Shahla A, Sirdah M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: Possible consequences for clinical diagnosis. Clin Lab Haematol. 2002;24:285-289.
23. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematologica. 2004;112:126-128.
24. Seltzer VL, Benjamin F, Deutsch S. Perimenopausal bleeding patterns and pathologic findings. JAMA. 1990;45:132-134.
25. Schreiber W. Iron, Porphyrin, and Bilirubin Metabolism. In: Kaplan LA, Pesce AJ, Kazmierczak SC, eds. Clinical Chemistry Theory, Analysis, Correlation, 4th edition. St. Louis: Mosby; 2003:657-674.
26. Behan K. Cessation of menstruation improves the correlation of FPG to hemoglobin A1c in Caucasian women. Clin Lab Sci. 2006;19:225-230.
27. Ridker R, Rifai D, Cook NR, et al. Non-HDL cholesterol, apolipoprotein A-1 and B100, standard lipid measures, lipid ratios and CRP as risk factors for cardiovascular disease in women. JAMA. 2005;294:326-333.
28. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. JAMA. 2004;351:2599-2610.
29. American Diabetes Association. Standards of Medical Care. Diabetes Care. 2006;29:S24-S42.
30. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.
31. Zhu S, Wang Z, Heshka S, et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. Am J Clin Nutr. 2002;76:743-749.